CRISPR Share Price

CRISPR Share Price

NASDAQ: CRSP | Mid Cap | Healthcare
$39.16
+$0.34 (0.88%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

CRISPR Stock Performance

Open
$38.36
Prev. Close
$38.82
Circuit Range
N/A
Day Range
$38.36 - $40.10
Year Range
$38.36 - $63.37
Volume
1,17,968
Average Traded
$39.40

CRISPR Share Price Today

As of 21 November 2026, CRISPR Therapeutics AG's share price is $39.16. The stock opened at $38.36, compared to its previous close of $38.82. During today's trading session, CRISPR Therapeutics AG's share price traded between $38.36 and $40.10, with an average price of $39.23. Over the past 52 weeks, the stock has recorded a high of $63.37 and a low of $38.36. In terms of performance, CRISPR Therapeutics AG's share price has declined by 30.26% over the last six months and is down 26.76% on a year-on-year basis.

CRISPR Share Price Chart

Line chart of the CRISPR price trend over the selected period. The price rose overall, ranging from 38.36 to 40.04, ending at 39.16.
$38.36$40.10
L
Show Current Price
H

CRISPR Stock Fundamentals & Key Indicators

Market Cap
$3.52B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.70
Revenue (TTM)
$3.51B
Return On Equity (TTM)
-27.68%
Profit Margin
-16569.80%
Debt to Equity
0.36
Quarterly Earnings Growth YoY
14.68%

CRISPR Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.86$1.46$10.18$12.67
Net Profit-$130.61-$122.93-$91.15-$111.44
Net Profit Margin-15187.21%-8419.86%-895.38%-879.56%
Income ChangeN/A5.88%25.85%-22.26%

CRISPR Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.20$371.21$37.31$3.51
Net Profit-$650.18-$153.61-$366.25-$581.60
Net Profit Margin-54181.67%-41.38%-981.64%-16569.80%
Income ChangeN/A76.37%-138.43%-58.80%

CRISPR Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets279.57304.9321.49390.03
Current Assets1985.671937.131908.081853.03
Total Assets2265.242242.032229.572243.06
Non Current Liabilities194.31222.17237.98246.47
Current Liabilities149.1287.78108.79121.11
Total Liabilities343.43309.95346.77367.58
Shareholders' Equity1921.811932.081882.81875.48

CRISPR Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-345.01-142.77-260.38-495.74
Investing-31.81-280.48374.65-258.66
Financing426.03331.9862.6638.59

About CRISPR

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

CRISPR Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$51.80
$39.09
-23.92%
Oct 2026
$55.45
$51.38
-7.32%
Sep 2026
$56.35
$55.44
-6.62%
Aug 2026
$48.23
$59.37
+23.80%
Jul 2026
$54.82
$47.95
-12.11%
Jun 2026
$54.48
$54.56
-2.83%
May 2026
$51.98
$56.15
+7.32%
Apr 2026
$48.73
$52.32
+10.10%
Mar 2026
$58.05
$47.52
-21.02%
Feb 2026
$49.25
$60.17
+20.34%
Jan 2026
$52.66
$50.00
-4.59%
Dec 2025
$51.93
$52.41
-1.99%

CRISPR Share Price FAQs